Matthew C Altman1, Agustin Calatroni2, Sima Ramratnam3, Daniel J Jackson3, Scott Presnell4, Mario G Rosasco4, Peter J Gergen5, Leonard B Bacharier6, George T O'Connor7, Megan T Sandel7, Meyer Kattan8, Robert A Wood9, Cynthia M Visness2, James E Gern3. 1. Immunology Division, Benaroya Research Institute Systems, Seattle, Wash; Department of Medicine, University of Washington, Seattle, Wash. Electronic address: maltman@benaroyaresearch.org. 2. Rho Federal Systems Division, Inc, Durham, NC. 3. Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis. 4. Immunology Division, Benaroya Research Institute Systems, Seattle, Wash. 5. National Institute of Allergy and Infectious Diseases, Rockville, Md. 6. Department of Pediatrics, Washington University School of Medicine and St Louis Children's Hospital, St Louis, Mo. 7. Department of Medicine, Boston University School of Medicine, Boston, Mass. 8. Department of Pediatrics, Columbia University Irving Medical Center, New York, NY. 9. Department of Pediatrics, Johns Hopkins University Medical Center, Baltimore, Md.
Abstract
BACKGROUND: Black and Hispanic children growing up in disadvantaged urban neighborhoods have the highest rates of asthma and related morbidity in the United States. OBJECTIVES: This study sought to identify specific respiratory phenotypes of health and disease in this population, associations with early life exposures, and molecular patterns of gene expression in nasal epithelial cells that underlie clinical disease. METHODS: The study population consisted of 442 high-risk urban children who had repeated assessments of wheezing, allergen-specific IgE, and lung function through 10 years of age. Phenotypes were identified by developing temporal trajectories for these data, and then compared to early life exposures and patterns of nasal epithelial gene expression at 11 years of age. RESULTS: Of the 6 identified respiratory phenotypes, a high wheeze, high atopy, low lung function group had the greatest respiratory morbidity. In early life, this group had low exposure to common allergens and high exposure to ergosterol in house dust. While all high-atopy groups were associated with increased expression of a type-2 inflammation gene module in nasal epithelial samples, an epithelium IL-13 response module tracked closely with impaired lung function, and a MUC5AC hypersecretion module was uniquely upregulated in the high wheeze, high atopy, low lung function group. In contrast, a medium wheeze, low atopy group showed altered expression of modules of epithelial integrity, epithelial injury, and antioxidant pathways. CONCLUSIONS: In the first decade of life, high-risk urban children develop distinct phenotypes of respiratory health versus disease that link early life environmental exposures to childhood allergic sensitization and asthma. Moreover, unique patterns of airway gene expression demonstrate how specific molecular pathways underlie distinct respiratory phenotypes, including allergic and nonallergic asthma.
BACKGROUND: Black and Hispanic children growing up in disadvantaged urban neighborhoods have the highest rates of asthma and related morbidity in the United States. OBJECTIVES: This study sought to identify specific respiratory phenotypes of health and disease in this population, associations with early life exposures, and molecular patterns of gene expression in nasal epithelial cells that underlie clinical disease. METHODS: The study population consisted of 442 high-risk urban children who had repeated assessments of wheezing, allergen-specific IgE, and lung function through 10 years of age. Phenotypes were identified by developing temporal trajectories for these data, and then compared to early life exposures and patterns of nasal epithelial gene expression at 11 years of age. RESULTS: Of the 6 identified respiratory phenotypes, a high wheeze, high atopy, low lung function group had the greatest respiratory morbidity. In early life, this group had low exposure to common allergens and high exposure to ergosterol in house dust. While all high-atopy groups were associated with increased expression of a type-2 inflammation gene module in nasal epithelial samples, an epithelium IL-13 response module tracked closely with impaired lung function, and a MUC5AC hypersecretion module was uniquely upregulated in the high wheeze, high atopy, low lung function group. In contrast, a medium wheeze, low atopy group showed altered expression of modules of epithelial integrity, epithelial injury, and antioxidant pathways. CONCLUSIONS: In the first decade of life, high-risk urban children develop distinct phenotypes of respiratory health versus disease that link early life environmental exposures to childhood allergic sensitization and asthma. Moreover, unique patterns of airway gene expression demonstrate how specific molecular pathways underlie distinct respiratory phenotypes, including allergic and nonallergic asthma.
Authors: Georg J Loss; Martin Depner; Alexander J Hose; Jon Genuneit; Anne M Karvonen; Anne Hyvärinen; Caroline Roduit; Michael Kabesch; Roger Lauener; Petra Ina Pfefferle; Juha Pekkanen; Jean-Charles Dalphin; Josef Riedler; Charlotte Braun-Fahrländer; Erika von Mutius; Markus J Ege Journal: Am J Respir Crit Care Med Date: 2016-04-15 Impact factor: 21.405
Authors: Daniel J Jackson; Michael D Evans; Ronald E Gangnon; Christopher J Tisler; Tressa E Pappas; Wai-Ming Lee; James E Gern; Robert F Lemanske Journal: Am J Respir Crit Care Med Date: 2011-09-29 Impact factor: 21.405
Authors: Susan V Lynch; Robert A Wood; Homer Boushey; Leonard B Bacharier; Gordon R Bloomberg; Meyer Kattan; George T O'Connor; Megan T Sandel; Agustin Calatroni; Elizabeth Matsui; Christine C Johnson; Henry Lynn; Cynthia M Visness; Katy F Jaffee; Peter J Gergen; Diane R Gold; Rosalind J Wright; Kei Fujimura; Marcus Rauch; William W Busse; James E Gern Journal: J Allergy Clin Immunol Date: 2014-06-04 Impact factor: 10.793
Authors: K Looi; A G Buckley; P J Rigby; L W Garratt; T Iosifidis; G R Zosky; A N Larcombe; F J Lannigan; K-M Ling; K M Martinovich; E Kicic-Starcevich; N C Shaw; E N Sutanto; D A Knight; A Kicic; S M Stick Journal: Clin Exp Allergy Date: 2018-02-20 Impact factor: 5.018
Authors: George T O'Connor; Susan V Lynch; Gordon R Bloomberg; Meyer Kattan; Robert A Wood; Peter J Gergen; Katy F Jaffee; Agustin Calatroni; Leonard B Bacharier; Avrahman Beigelman; Megan T Sandel; Christine C Johnson; Ali Faruqi; Clark Santee; Kei E Fujimura; Douglas Fadrosh; Homer Boushey; Cynthia M Visness; James E Gern Journal: J Allergy Clin Immunol Date: 2017-09-19 Impact factor: 10.793
Authors: James E Gern; G Daniel Brooks; Patricia Meyer; Andy Chang; Kunling Shen; Michael D Evans; Chris Tisler; Douglas Dasilva; Kathy A Roberg; Lance D Mikus; Louis A Rosenthal; Carole J Kirk; Peter A Shult; Abhik Bhattacharya; Zhanhai Li; Ronald Gangnon; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2005-11-28 Impact factor: 10.793
Authors: Gang Chen; Thomas R Korfhagen; Yan Xu; Joseph Kitzmiller; Susan E Wert; Yutaka Maeda; Alexander Gregorieff; Hans Clevers; Jeffrey A Whitsett Journal: J Clin Invest Date: 2009-09-14 Impact factor: 14.808
Authors: Alex Poole; Cydney Urbanek; Celeste Eng; Jeoffrey Schageman; Sean Jacobson; Brian P O'Connor; Joshua M Galanter; Christopher R Gignoux; Lindsey A Roth; Rajesh Kumar; Sharon Lutz; Andrew H Liu; Tasha E Fingerlin; Robert A Setterquist; Esteban G Burchard; Jose Rodriguez-Santana; Max A Seibold Journal: J Allergy Clin Immunol Date: 2014-02-02 Impact factor: 10.793
Authors: Selene M Clay; Nathan Schoettler; Andrew M Goldstein; Peter Carbonetto; Matthew Dapas; Matthew C Altman; Mario G Rosasco; James E Gern; Daniel J Jackson; Hae Kyung Im; Matthew Stephens; Dan L Nicolae; Carole Ober Journal: Genome Med Date: 2022-05-24 Impact factor: 15.266
Authors: Matthew C Altman; Kaitlin Flynn; Mario G Rosasco; Matthew Dapas; Meyer Kattan; Stephanie Lovinsky-Desir; George T O'Connor; Michelle A Gill; Rebecca S Gruchalla; Andrew H Liu; Jacqueline A Pongracic; Gurjit K Khurana Hershey; Edward M Zoratti; Stephen J Teach; Deepa Rastrogi; Robert A Wood; Leonard B Bacharier; Petra LeBeau; Peter J Gergen; Alkis Togias; William W Busse; Scott Presnell; James E Gern; Carole Ober; Daniel J Jackson Journal: J Allergy Clin Immunol Date: 2021-05-18 Impact factor: 10.793
Authors: Marcus M Soliai; Atsushi Kato; Britney A Helling; Catherine T Stanhope; James E Norton; Katherine A Naughton; Aiko I Klinger; Emma E Thompson; Selene M Clay; Soyeon Kim; Juan C Celedón; James E Gern; Daniel J Jackson; Matthew C Altman; Robert C Kern; Bruce K Tan; Robert P Schleimer; Dan L Nicolae; Jayant M Pinto; Carole Ober Journal: Genome Med Date: 2021-10-10 Impact factor: 11.117
Authors: Charles Washington; Matthew Dapas; Arjun Biddanda; Kevin M Magnaye; Ivy Aneas; Britney A Helling; Brooke Szczesny; Meher Preethi Boorgula; Margaret A Taub; Eimear Kenny; Rasika A Mathias; Kathleen C Barnes; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Jessica D Gereige; Melanie Makhija; Rebecca S Gruchalla; Michelle A Gill; Andrew H Liu; Deepa Rastogi; William Busse; Peter J Gergen; Cynthia M Visness; Diane R Gold; Tina Hartert; Christine C Johnson; Robert F Lemanske; Fernando D Martinez; Rachel L Miller; Dennis Ownby; Christine M Seroogy; Anne L Wright; Edward M Zoratti; Leonard B Bacharier; Meyer Kattan; George T O'Connor; Robert A Wood; Marcelo A Nobrega; Matthew C Altman; Daniel J Jackson; James E Gern; Christopher G McKennan; Carole Ober Journal: Genome Med Date: 2022-09-29 Impact factor: 15.266
Authors: Thomas Iosifidis; Erika N Sutanto; Samuel T Montgomery; Patricia Agudelo-Romero; Kevin Looi; Kak-Ming Ling; Nicole C Shaw; Luke W Garratt; Jessica Hillas; Kelly M Martinovich; Elizabeth Kicic-Starcevich; Shyan Vijayasekaran; Francis J Lannigan; Paul J Rigby; Darryl A Knight; Stephen M Stick; Anthony Kicic Journal: J Pers Med Date: 2021-12-07